# Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

> **NCT03521596** · — · COMPLETED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 300 (actual)

## Conditions studied

- Waldenstrom Macroglobulinemia

## Interventions

- **OTHER:** MRD and clonal evolution

## Key facts

- **NCT ID:** NCT03521596
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-28
- **Primary completion:** 2020-10-06
- **Final completion:** 2025-10-02
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03521596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03521596, "Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03521596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*